Investigating the role of the immunoproteasome in the efficacy of oncolytic virotherapy against breast cancer

研究免疫蛋白酶体在溶瘤病毒治疗乳腺癌疗效中的作用

• 批准号: 453483
• 负责人: Bourgeois-Daigneault Marie-Claude
• 金额: $ 4.37万
• 依托单位: Centre hospitalier de l'Universit de Montral (CHUM)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-03-01 至 2023-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=453483&lang=en
• 关键词: Immunotherapy; Oncolytic Viruses &Amp

Oncolytic viruses (OVs) are viruses that specifically kill cancer cells while leaving normal tissues unharmed. Our recent research has focused on breast cancer: we developed several OV-therapies that greatly improved outcomes and were able to uncover the

溶瘤病毒（OV）是特异性杀死癌细胞而不伤害正常组织的病毒。我们最近的研究集中在乳腺癌上：我们开发了几种OV疗法，大大改善了结果，并能够揭示乳腺癌的发病机制。